Fresenius successfully placed €1.0 billion of Schuldschein Loans. Given the substantial investor demand, the volume of the issuance was significantly upsized. The Schuldschein Loans were issued in tranches of five, seven and ten years with fixed and variable interest rates. The proceeds will be used general corporate purposes and the acquisition of Quirónsalud. Funding of the transaction will be on January 31, 2017. More than 230 investors participated. The placement was arranged by Bayerische Landesbank, Deutsche Bank AG, DZ BANK and NORD/LB Norddeutsche Landesbank Girozentrale.
Fresenius Helios has laid the foundation stone for a new main building at HELIOS Hospital Dr. Horst Schmidt Kliniken in the German city of Wiesbaden, near Frankfurt. The seven-story structure, with 96,000 square meters (about 1 million square feet) of floor space, is being erected beside the existing clinic. It will have 22 operating rooms, more than 900 beds, and a design that significantly reduces distances and waiting times for patients. HELIOS is investing about €200 million in the new building, while the state of Hesse is contributing €68 million. Completion is scheduled for 2020.
Fresenius increased its 2013 Senior Credit Agreement by €1.2 billion incremental facilities as a further step to fund the acquisition of IDC Salud Holding S.L.U. (Quironsalud) by Fresenius Helios. A bridge facility of €3.75 billion was already signed in September 2016. The incremental facilities consist of an incremental term loan A of €900 million and an incremental revolving facility of €300 million. The transaction was well received by investors and substantially oversubscribed. More than 40 financial institutions participated.
A website published by Fresenius Kabi Germany on nutritional therapies for different types of patients has won the Health Media Award. The jury praised www.ernaehrungstherapie-hilft.de for its comprehensive information, a user-friendly presentation, and the site's attractive interactive elements. The German-language site targets not only patients and their family members, but also physicians, nutritionists and caregivers.
Two of Fresenius Vamed’s rehabilitation clinics in Austria have again been certified as “World Hospitals” by the Joint Commission International (JCI). The renewed certifications mean the Rehabilitation Clinic Montafon and the Neurological Therapy Center Gmundnerberg remain among the approximately 800 hospitals worldwide recognized by the JCI as top-tier facilities. A certification as a World Hospital is valid for three years. Quality standards are verified annually by the U.S.-based JCI, the world’s leading competence center for quality and patient safety in healthcare.
Fresenius Vamed has successfully completed another major project in Germany’s healthcare system, an emergency care center at the Charité university hospital in Berlin. The new center was built in partnership with the construction company Züblin for about €70 million. It will cover about 8,000 square meters (86,000 square feet) and host 15 operating rooms, a 71-bed intensive care ward and a central emergency department.
The price increase for hospital services in Germany has been set at 2.50% for 2017. This is in line with the level of past years.
Construction has begun at the HELIOS hospital in Hildesheim, a city in the German state of Lower Saxony, on a fourth hospital block. The nearly 6,000-square-meter (65,000 square feet), three-story building will house wards for ear, nose and throat medicine, oral-facial, and thoracic surgery. A pulmonary clinic acquired in 2014, currently situated in nearby Diekholzen, will be relocated to the new building including a sleep lab twice as large as the existing one. HELIOS is investing about €13 million in the new block of wards. Completion is expected in 2018.
Following Fresenius’ announcement to acquire the largest Spanish hospital operator Quirónsalud, the rating agencies Standard & Poor’s (BBB-, stable), Moody’s (Baa3, stable) and Fitch (BBB-, stable) are affirming the corporate credit ratings of Fresenius.
Annual Report 2015 (US-GAAP) (PDF, 3.18 MB)
Fresenius "At a Glance" (PDF, 163 KB)
Book "100 Years of Fresenius" (PDF, 6.25 MB)
Fresenius Factsheet Q3 2016 (PDF, 311 KB)
Fresenius Medical Care "Profile" (PDF, 1.20 MB)
Fresenius Medical Care Magazine "Understand" (PDF, 5.65 MB)
Social Media Guidelines (PDF, 1.97 MB)
Investor Relations General Presentation (PDF, 495 KB)